WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H413526
CAS#: 138356-08-8 (free base)
Description: BD 1008 Free Base is a selective sigma receptor antagonist, with a reported binding affinity of Kᵢ = 2 ± 1 nM for the sigma-1 receptor and 4 times selectivity over the sigma-2 receptor.
Hodoodo Cat#: H413526
Name: BD 1008 Free Base
CAS#: 138356-08-8 (free base)
Chemical Formula: C15H22Cl2N2
Exact Mass: 300.12
Molecular Weight: 301.260
Elemental Analysis: C, 59.80; H, 7.36; Cl, 23.53; N, 9.30
Related CAS #: 138356-08-8 (free base) 138356-09-9 (HBr)
Synonym: BD 1008 Free Base; BD1008; BD-1008
IUPAC/Chemical Name: 1-Pyrrolidineethanamine, N-(2-(3,4-dichlorophenyl)ethyl)-N-methyl-
InChi Key: ASGIQUHBAVIOTI-UHFFFAOYSA-N
InChi Code: InChI=1S/C15H22Cl2N2/c1-18(10-11-19-7-2-3-8-19)9-6-13-4-5-14(16)15(17)12-13/h4-5,12H,2-3,6-11H2,1H3
SMILES Code: CN(CCC1=CC=C(Cl)C(Cl)=C1)CCN2CCCC2
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
To be determined | 0.0 | 0.00 |
The following data is based on the product molecular weight 301.26 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Monnet FP, de Costa BR, Bowen WD. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices. Br J Pharmacol. 1996 Sep;119(1):65-72. doi: 10.1111/j.1476-5381.1996.tb15678.x. PMID: 8872358; PMCID: PMC1915737.
2: Garcés-Ramírez L, Green JL, Hiranita T, Kopajtic TA, Mereu M, Thomas AM, Mesangeau C, Narayanan S, McCurdy CR, Katz JL, Tanda G. Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis. Biol Psychiatry. 2011 Feb 1;69(3):208-17. doi: 10.1016/j.biopsych.2010.07.026. Epub 2010 Oct 15. PMID: 20950794; PMCID: PMC3015019.
3: Hiranita T, Soto PL, Tanda G, Kopajtic TA, Katz JL. Stimulants as specific inducers of dopamine-independent σ agonist self-administration in rats. J Pharmacol Exp Ther. 2013 Oct;347(1):20-9. doi: 10.1124/jpet.113.207522. Epub 2013 Aug 1. PMID: 23908387; PMCID: PMC3781409.
4: Desai RI, Grandy DK, Lupica CR, Katz JL. Pharmacological characterization of a dopamine transporter ligand that functions as a cocaine antagonist. J Pharmacol Exp Ther. 2014 Jan;348(1):106-15. doi: 10.1124/jpet.113.208538. Epub 2013 Nov 5. PMID: 24194528; PMCID: PMC3868881.
5: Hiranita T, Soto PL, Tanda G, Katz JL. Reinforcing effects of sigma-receptor agonists in rats trained to self-administer cocaine. J Pharmacol Exp Ther. 2010 Feb;332(2):515-24. doi: 10.1124/jpet.109.159236. Epub 2009 Nov 5. PMID: 19892920; PMCID: PMC2812106.
6: Hiranita T, Soto PL, Kohut SJ, Kopajtic T, Cao J, Newman AH, Tanda G, Katz JL. Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors. J Pharmacol Exp Ther. 2011 Nov;339(2):662-77. doi: 10.1124/jpet.111.185025. Epub 2011 Aug 22. PMID: 21859929; PMCID: PMC3199989.
7: Hudzik TJ, De Costa BR, McMillan DE. Sigma receptor-mediated emetic response in pigeons: agonists, antagonists and modifiers. Eur J Pharmacol. 1993 May 19;236(2):279-87. doi: 10.1016/0014-2999(93)90599-d. PMID: 8100532.
8: Beninger RJ. International Behavioral Neuroscience Society - Ninth meeting. Neurochemistry of feeding. IDrugs. 2000 Jul;3(7):745-6. PMID: 16080042.
9: Couture S, Debonnel G. Modulation of the neuronal response to N-methyl-D- aspartate by selective sigma2 ligands. Synapse. 1998 May;29(1):62-71. doi: 10.1002/(SICI)1098-2396(199805)29:1<62::AID-SYN5>3.0.CO;2-9. PMID: 9552175.
10: Berardi F, Ferorelli S, Colabufo NA, Leopoldo M, Perrone R, Tortorella V. A multireceptorial binding reinvestigation on an extended class of sigma ligands: N-[omega-(indan-1-yl and tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine reveal high affinities towards sigma1 and EBP sites. Bioorg Med Chem. 2001 May;9(5):1325-35. doi: 10.1016/s0968-0896(01)00011-6. PMID: 11377189.